Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:PRG NYSE:RSI NASDAQ:UPST NASDAQ:VVOS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePRGPROG$36.95+3.1%$32.67$25.80▼$41.14$1.48B1.82496,912 shs427,365 shsRSIRush Street Interactive$27.57+5.5%$24.94$13.20▼$29.24$6.41B1.582.00 million shs1.84 million shsUPSTUpstart$31.06+0.2%$29.82$23.97▼$87.30$2.97B2.264.96 million shs3.99 million shsVVOSVivos Therapeutics$0.70-19.5%$0.89$0.55▼$7.95$9.73M6.1871,820 shs1.26 million shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePRGPROG+1.85%-2.79%-0.92%+18.06%+23.41%RSIRush Street Interactive-0.19%+3.21%-5.73%+25.98%+95.25%UPSTUpstart+4.24%-7.77%+7.04%+10.09%-42.94%VVOSVivos Therapeutics+0.64%+27.01%+30.87%-35.32%-60.99%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePRGPROG$36.95+3.1%$32.67$25.80▼$41.14$1.48B1.82496,912 shs427,365 shsRSIRush Street Interactive$27.57+5.5%$24.94$13.20▼$29.24$6.41B1.582.00 million shs1.84 million shsUPSTUpstart$31.06+0.2%$29.82$23.97▼$87.30$2.97B2.264.96 million shs3.99 million shsVVOSVivos Therapeutics$0.70-19.5%$0.89$0.55▼$7.95$9.73M6.1871,820 shs1.26 million shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePRGPROG+1.85%-2.79%-0.92%+18.06%+23.41%RSIRush Street Interactive-0.19%+3.21%-5.73%+25.98%+95.25%UPSTUpstart+4.24%-7.77%+7.04%+10.09%-42.94%VVOSVivos Therapeutics+0.64%+27.01%+30.87%-35.32%-60.99%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePRGPROG 2.86Moderate Buy$43.7018.27% UpsideRSIRush Street Interactive 2.85Moderate Buy$29.256.11% UpsideUPSTUpstart 2.25Hold$45.7947.41% UpsideVVOSVivos Therapeutics 2.25Hold$2.80299.89% UpsideCurrent Analyst Ratings BreakdownLatest UPST, PRG, RSI, and VVOS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/4/2026VVOSVivos Therapeutics Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$3.00 ➝ $3.105/20/2026RSIRush Street Interactive CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform5/20/2026RSIRush Street Interactive Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$27.00 ➝ $30.005/19/2026PRGPROG Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/13/2026PRGPROG Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C)5/8/2026UPSTUpstart MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$45.005/7/2026UPSTUpstart Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$35.005/6/2026UPSTUpstart Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)5/6/2026UPSTUpstart Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$40.005/6/2026UPSTUpstart Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$56.00 ➝ $46.005/6/2026UPSTUpstart B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$66.00 ➝ $54.00(Data available from 6/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPRGPROG$2.41B0.61$46.77 per share0.79$18.86 per share1.96RSIRush Street Interactive$1.13B5.65$0.46 per share59.61$1.32 per share20.88UPSTUpstart$1.04B2.85$0.84 per share36.89$8.21 per share3.78VVOSVivos Therapeutics$17.44M0.56N/AN/A($0.16) per share-4.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePRGPROG$146.79M$3.6610.106.97N/A5.88%21.94%9.54%7/29/2026 (Estimated)RSIRush Street Interactive$33.31M$0.3188.9344.46N/A2.98%17.21%8.00%7/29/2026 (Estimated)UPSTUpstart$53.60M$0.3881.7418.270.804.34%5.63%1.49%8/4/2026 (Estimated)VVOSVivos Therapeutics-$21.17M-$2.14N/AN/AN/A-127.70%-2,325.64%-98.12%8/18/2026 (Estimated)Latest UPST, PRG, RSI, and VVOS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2026Q1 2026VVOSVivos Therapeutics-$0.45-$0.52-$0.07-$0.52$4.35 million$5.14 million5/5/2026Q1 2026UPSTUpstart$0.39-$0.07-$0.46-$0.07$301.30 million$308.21 million4/29/2026Q1 2026PRGPROG$0.78$1.24+$0.46$0.89$732.70 million$742.67 million4/28/2026Q1 2026RSIRush Street Interactive$0.12$0.14+$0.02$0.08$330.83 million$370.36 million4/15/2026Q4 2025VVOSVivos Therapeutics-$0.4950-$0.58-$0.0850-$0.58$7.10 million$3.82 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthPRGPROG$0.561.52%-44.37%15.30%2 YearsRSIRush Street InteractiveN/AN/AN/AN/AN/AUPSTUpstartN/AN/AN/AN/AN/AVVOSVivos TherapeuticsN/AN/AN/AN/AN/ALatest UPST, PRG, RSI, and VVOS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2026PRGPROGquarterly$0.141.7%5/19/20265/19/20266/2/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPRGPROG1.214.272.41RSIRush Street InteractiveN/A1.961.96UPSTUpstartN/A0.490.49VVOSVivos Therapeutics3.310.270.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPRGPROG97.92%RSIRush Street Interactive24.78%UPSTUpstart63.01%VVOSVivos Therapeutics26.35%Insider OwnershipCompanyInsider OwnershipPRGPROG3.72%RSIRush Street Interactive52.89%UPSTUpstart17.29%VVOSVivos Therapeutics2.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePRGPROG1,15140.07 million38.58 millionNot OptionableRSIRush Street Interactive470232.70 million109.62 millionNot OptionableUPSTUpstart1,40595.71 million79.16 millionOptionableVVOSVivos Therapeutics16013.90 million13.60 millionOptionableUPST, PRG, RSI, and VVOS HeadlinesRecent News About These CompaniesVivos Therapeutics, Inc. to Present at The Small Cap Showcase & WTR Insights on June 9, 2026June 8 at 1:51 PM | quiverquant.comQVivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026June 8 at 1:39 PM | globenewswire.comVivos Therapeutics Announces Debt Exchange Agreement with Streeterville Capital to Strengthen Financial PositionJune 5, 2026 | quiverquant.comQVivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq ListingJune 5, 2026 | globenewswire.comVivos Therapeutics Inc (VVOS) Q1 2026 Earnings Call Highlights: Revenue Surges Amid Strategic ShiftsMay 29, 2026 | finance.yahoo.comVivos Therapeutics Balances Rapid Growth With Cash StrainMay 22, 2026 | tipranks.comVivos Therapeutics Earnings Call: Growth Meets Cash StrainMay 21, 2026 | tipranks.comVivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational UpdateMay 21, 2026 | finanznachrichten.deVivos Therapeutics, Inc. (VVOS) Q1 2026 Earnings Call TranscriptMay 21, 2026 | seekingalpha.comVivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational UpdateMay 20, 2026 | globenewswire.comVivos Therapeutics Delays Quarterly FilingMay 15, 2026 | tipranks.comAnalysts see 200%+ upside in these 3 high-risk stocks: here's why?May 9, 2026 | invezz.comIVivos Therapeutics (VVOS) price target decreased by 51.67% to 2.47April 29, 2026 | msn.comVivos Therapeutics Faces Nasdaq Listing Compliance ChallengesApril 22, 2026 | tipranks.comVivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2025 Earnings Call TranscriptApril 17, 2026 | insidermonkey.comVivos Therapeutics Q4 Earnings Call HighlightsApril 17, 2026 | defenseworld.netDVivos Therapeutics Balances Growth Hopes With Cash StrainApril 16, 2026 | tipranks.comVivos targets cash flow positive operations by end of 2026 as it scales SO teams with $500,000+ monthly collections potentialApril 16, 2026 | seekingalpha.comVivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ...April 16, 2026 | finance.yahoo.comVivos Therapeutics, Inc. (VVOS) Q4 2025 Earnings Call TranscriptApril 15, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThese 3 CLO ETFs Target a Niche Corner of the Fixed-Income MarketBy Nathan Reiff | May 31, 2026Dollar Tree Keeps Winning After Family Dollar DivorceBy Leo Miller | May 29, 2026If the Market Rally Stalls, This ETF Can Insulate PortfoliosBy Jessica Mitacek | May 28, 2026Insider Buying Says Upstart Isn’t Down for the CountBy Thomas Hughes | May 18, 20263 ETFs For the Coming Genomics RevolutionBy Nathan Reiff | June 7, 2026UPST, PRG, RSI, and VVOS Company DescriptionsPROG NYSE:PRG$36.95 +1.10 (+3.07%) Closing price 03:59 PM EasternExtended Trading$36.90 -0.05 (-0.15%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.PROG Holdings, Inc. (NYSE:PRG) is a financial technology holding company based in Salt Lake City, Utah with three business segments: Progressive Leasing, which offers lease-to-own transactions primarily to credit-challenged consumers through e-commerce and point-of-sale retail partners, via online, mobile, and in-store solutions; Vive Financial, which provides consumers who may not qualify for traditional prime lending with a variety of second-look, revolving credit products through private label and branded credit cards; and Four Technologies, which provides consumers of all credit backgrounds Buy Now, Pay Later (BNPL) options through four interest-free installments via its platform, Four.Rush Street Interactive NYSE:RSI$27.57 +1.43 (+5.46%) Closing price 03:59 PM EasternExtended Trading$27.59 +0.02 (+0.08%) As of 04:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Rush Street Interactive, Inc. operates as an online casino and sports betting company in the United States, Canada, Mexico, and rest of Latin America. It provides real-money online casino, online and retail sports betting, and social gaming services. In addition, the company offers full suite of games comprising of bricks-and-mortar casinos, table games, and slot machines. The company markets its online casino and sports betting under BetRivers, PlaySugarHouse, and RushBet brands. Rush Street Interactive, Inc. was founded in 2012 and is headquartered in Chicago, Illinois.Upstart NASDAQ:UPST$31.06 +0.06 (+0.19%) Closing price 04:00 PM EasternExtended Trading$31.14 +0.08 (+0.25%) As of 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California.Vivos Therapeutics NASDAQ:VVOS$0.70 -0.17 (-19.52%) Closing price 04:00 PM EasternExtended Trading$0.71 +0.01 (+0.83%) As of 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The J.M. Smucker Company’s Dividend: Too Sweet to Ignore? Apple's Siri AI Was Finally Announced, So Why Is the Stock Tanking? From Crypto to AI: Insiders Are Trading These 3 Stocks The Case for Intel Over Pure-Play Quantum Firms Has Temu-Owner PDD's Story Changed After Double Miss? Campbell's Soup Stock: Deep Value and a 7% Dividend Yield Walmart's No. 2 Ranking Hides a Digital Transformation Story AirJoule Technologies: A Cool Shot at a Multibagger Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
